Invesaro

Stocks Comparison

Medtronic vs TransMedics: revenue, profit, margins and growth compared

Medtronic brought in $36.4B of revenue in fiscal 2026, TransMedics $605.5M in fiscal 2025. Revenue changed by +8.4% at Medtronic and +37.1% at TransMedics on the year before, so TransMedics grew faster. Medtronic kept 13.2% of its revenue as net profit, TransMedics 31.4%. Free cash flow was $5.4B at Medtronic and $133.6M at TransMedics.

Side by side, latest fiscal year

MDTTMDX
Fiscal year endedFY2026 (April 24, 2026)FY2025 (December 31, 2025)
Revenue$36.4B$605.5M
Revenue growth+8.4%+37.1%
Net income$4.8B$190.3M
Net margin13.2%31.4%
Free cash flow$5.4B$133.6M
Free cash flow margin14.9%22.1%
Earnings per share (diluted)$3.73$4.87
Cash$1.9B$488.9M
Debt$26.2B$10M
Price to earnings23.817.5
Market value$113.5B$3B
Dividend yield3.20%n/a
Rank by revenue in sector#21 of 523 · Health care#182 of 523 · Health care

Over the years

Revenue
MDT FY2019: $30.6BMDT FY2020: $28.9BMDT FY2021: $30.1BMDT FY2022: $31.7BMDT FY2023: $31.2BMDT FY2024: $32.4BMDT FY2025: $33.5BMDT FY2026: $36.4BTMDX FY2019: $14.7MTMDX FY2019: $25.8MTMDX FY2020: $28.4MTMDX FY2021: $31.4MTMDX FY2022: $93.5MTMDX FY2023: $241.6MTMDX FY2024: $441.5MTMDX FY2025: $605.5MFY19FY20FY21FY22FY23FY24FY25FY26
MDT $36.4BTMDX $605.5M
Net income
MDT FY2019: $4.6BMDT FY2020: $4.8BMDT FY2021: $3.6BMDT FY2022: $5BMDT FY2023: $3.8BMDT FY2024: $3.7BMDT FY2025: $4.7BMDT FY2026: $4.8BTMDX FY2019: -$23.8MTMDX FY2019: -$33.5MTMDX FY2020: -$28.7MTMDX FY2021: -$44.2MTMDX FY2022: -$36.2MTMDX FY2023: -$25MTMDX FY2024: $35.5MTMDX FY2025: $190.3MFY19FY20FY21FY22FY23FY24FY25FY26
MDT $4.8BTMDX $190.3M
Net margin
MDT FY2019: 15.2%MDT FY2020: 16.6%MDT FY2021: 12.0%MDT FY2022: 15.9%MDT FY2023: 12.0%MDT FY2024: 11.4%MDT FY2025: 13.9%MDT FY2026: 13.2%TMDX FY2019: -162.1%TMDX FY2019: -129.8%TMDX FY2020: -101.4%TMDX FY2021: -140.9%TMDX FY2022: -38.8%TMDX FY2023: -10.4%TMDX FY2024: 8.0%TMDX FY2025: 31.4%FY19FY20FY21FY22FY23FY24FY25FY26
MDT 13.2%TMDX 31.4%
Revenue growth
MDT FY2020: -5.4%MDT FY2021: +4.2%MDT FY2022: +5.2%MDT FY2023: -1.4%MDT FY2024: +3.6%MDT FY2025: +3.6%MDT FY2026: +8.4%TMDX FY2019: +76.3%TMDX FY2020: +9.7%TMDX FY2021: +10.7%TMDX FY2022: +197.8%TMDX FY2023: +158.5%TMDX FY2024: +82.7%TMDX FY2025: +37.1%FY19FY20FY21FY22FY23FY24FY25FY26
MDT +8.4%TMDX +37.1%
Free cash flow
MDT FY2019: $5.9BMDT FY2020: $6BMDT FY2021: $4.9BMDT FY2022: $6BMDT FY2023: $4.6BMDT FY2024: $5.2BMDT FY2025: $5.2BMDT FY2026: $5.4BTMDX FY2019: -$26.4MTMDX FY2019: -$32.5MTMDX FY2020: -$30.7MTMDX FY2021: -$32.4MTMDX FY2022: -$57.7MTMDX FY2023: -$164.9MTMDX FY2024: -$80.9MTMDX FY2025: $133.6MFY19FY20FY21FY22FY23FY24FY25FY26
MDT $5.4BTMDX $133.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Medtronic and TransMedics

Which is bigger by revenue, Medtronic or TransMedics?

Medtronic is bigger by revenue: $36.4B in fiscal 2026, against $605.5M for TransMedics in fiscal 2025.

Which keeps more of its revenue as profit, Medtronic or TransMedics?

Medtronic had a net margin of 13.2% in fiscal 2026; TransMedics had 31.4% in fiscal 2025.

Which grew revenue faster, Medtronic or TransMedics?

In their latest fiscal years revenue changed by +8.4% at Medtronic and +37.1% at TransMedics.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies